David Williams at the Health Business Blog is this week’s host of Health Wonk Review. His style is brief and clear…I’m envious…
Insight, analysis & opinion from Joe Paduda
Insight, analysis & opinion from Joe Paduda
David Williams at the Health Business Blog is this week’s host of Health Wonk Review. His style is brief and clear…I’m envious…
My firm, Health Strategy Associates, is conducting the Third Annual Survey of Prescription Drug Management in Workers Comp, and I’m hoping to have the final report completed before the end of April. Here are a couple of interesting bits that have come up in the 20+ interviews conducted to date.
1. There is a rather striking difference in the pharmacy inflation rate between what I would characterize as less- and more-sophisticated payers. Some payers have held their inflation rates down in the lower single digits, others are seeing trend rates above 15%.
2. Claim frequency decreases get part of the credit for low pharmacy inflation, but not all of it.
3. The number of PBMs is growing, but no PBM has a dominant market position. In fact, many senior execs don’t know much about the PBMs beyond their names.
4. Cost inflation tends to be attributed to more “designer” drugs, e.g. more expensive branded drugs being prescribed when a cheaper generic would likely work; direct to consumer advertising’s impact on consumers, and more claimants getting more drugs for longer periods.
5. This last is probably the most consistent thread running throughout the interviews – a heightened awareness of and concern about the sheer volume of drugs prescribed.
I’ll post additional highlights when they make themselves apparent. If you want a copy of the survey report, email me at jpaduda@healthstrategyassoc.com.
OK, congratulations to Massachusetts’ legislators and governor for creating the nation’s first potentially viable universal coverage program. While everyone is busy congratulating each other, (free registration required) I hate to be the one to harsh their mellow. But so I shall.
I’ve read numerous reports of the new program, but nowhere have I seen any reference to any aspect of the program that convinces me it will work over the long haul. Why not?
There don’t appear to be any cost-control mechanisms, price or fee or utilization or frequency controls, nor any constraints on supply.
Yes, the program should eliminate excessive costs in the system due to cost-shifting, as long as the fees paid by all payers are high enough to cover associated costs. And, with cost-shifting accounting for about $1000 of the average family’s annual health insurance premium, the savings should be significant.
But that’s it. I’m afraid Massachusetts’ noble efforts have built a giant new demand mechanism, one that will produce healthier people, a one-time drop in premiums due to elimination of cost shifting (fingers crossed on that one), and ever-higher costs for the state’s citizens.
If we are relying on private industry’s innovators to come up with a solution, one that will effectively hold down costs over the long term for the entire population, we may have a long wait. For there are few incentives and lots of risks for any insurer to develop bold new programs when all they have to do is out-market their competition to capture their slice of the Mass pie. And there certainly has been ample opportunity for private companies to develop and deliver new programs over the past two decades, programs that could successfully constrain costs. That just hasn’t happened.
I hope I’m wrong, I hope I’m wrong, I hope I’m wrong.
But if I’m not, naysayers will have another example of an “experiment” that did not work out, an example they can, and will, point to as an image of another failed attempt by government to solve a huge problem.
The reality is government did not do too much, but rather did not go far enough.
Further proof that health wonks with too much time on their hands can create havoc comes in Fard Johnmar’s recent post about fellow wonks Matt Holt, Trapper Michael, Kate Steadman, Nick Genes et al.
Accolades and cheers for Fard, who gets the “most creative” award, and to Kate for passing it on to those of us too lazy to find it on our own.
If you don’t get it, time to put aside that work and dive deeply into the wonk world…
I’m in my hotel in Salt Lake City (a beautiful place) checking out what fellow bloggers are talking about, and hop over to Over My Med Body to see what Graham is up to. One of his recent posts is about the difference in health care costs in the US and Canada, wherein Graham notes the Canadians are spending about $900 less per person than we are, funds which could go to higher wages, etc.
In the comments section, a physician moans about the problems with rationing inherent up North, and states that no red-blooded American would put up with that, while placing most of the blame for our exorbitant health care costs squarely upon defensiivce medicine.
Which inspired the following rant.
If I hear one more doc complaining about defensive medicine and tort costs I’ll throw them under the wheels of their golf cart. Care is rationed in the US – for the 45 million uninsured, for Medicaid recipients, and for those in staff and group model HMOs as well as anyne who has to comply with precert rules.
This rationing argument is nonsense, not only because have de facto rationing but also because it is a red herring. Canadians, Swiss, Norwegians, and citizens of 33 other countries are healthier than Americans, yet we pay about 50% more than they do.
So the good Dr. Thompson et al are delivering an inferior product and charging much more for it.
Finally, what is wrong with rationing of care? The question is NOT how many MRI machines does Canada have compared to Portland, it is what is the right number of MRI machines? And my bet is many of Portland’s MRI machines are owned by docs, who make money by sending patients there, all the while hiding behind the covers of “defensive medicine”.
And this before the morning caffiene…
For the dozen folks who find this remotely interesting – A few factoids and interesting tidbits from around the WC PBM world.
The legislative efforts in California to address repackagers and dispensing of drugs by physicians appears to be stalled, and may not progress this year. This is bad news for payers and policyholders, as repackaged drugs account for over 50% of drug costs in California and that number is heading up.
Third party billers pay pharmacies about what most PBMs do, thus the reason pharmacies send their scripts to TPBs is because it is less work.
Sources indicate about 2% of all workers comp scripts are never picked up. If the pharmacy billed the script through a PBM, it will be reversed and the PBM and payer credited. This does not appear to be happening with third party billers. Anyone out there ever had a third party biller come back to them and reverse a charge? Anyone???
One third party biller strategy being discussed by a major comp payer is to require the biller to verify that each script was picked up. This could be in the form of a photocopy of the signature log or attestation by an officer of the TPB.
A source’s billing and payment data indicate that many payers, including at least two of the top five national WC insurers, pay third party billers at or close to billed charges in states without fee schedules. Meanwhile, other payers are cutting those bills to AWP-10% +$3.00 and not getting much pushback.
Word has it that Kroger’s is getting paid at straight AWP by their third party biller…no wonder they are not contracting with any workers comp PBMs.
Meanwhile, Medco is forcing pharmacies to accept group health reimbursement for their (very few) workers comp clients. Workers comp does not appear to be anything more than an accomodation for a very few of Medco’s largest customers, as Medco does not actively sell into the comp sector. My sense is if Medco did have more WC business, they very likely would have a lot more pushback from the pharmacy chains.
White House Domestic Policy Advisor Allan Hubbard has been making waves of late, speaking out on behalf of consumerism in health care, advocating bigger tax breaks for health savings accounts, and demanding hospitals disclose their pricing information so consumers can make better decisions.
I’ve been blogging on consumerism in health care, the lack of useful data on prices and outcomes, and the complexities of health care buying decisions for well over a year, so no need to review those issues.
Except, one of his statements manages to simultaneously be both blatantly jingoistic and completely misleading. Here’s the quote from Sunday’s NYTimes “”no consumer is better than the American consumer at driving prices down and quality up.”
I’m not sure if Hubbard’s statement is a tortured call for patriotism as the solution to health care’s ills, or if he actually believes this drivel. Doesn’t really matter.
Every other country has some variation of nationalized health care, with some entirely nationalized (Canada), others mostly public (Britian), and others with a strict national requirement for care delivered by private providers (Switzerland). Yes, there are lots of variations and permutations, but every other country uses government to set prices for health care, not consumers.
And by the way, Allan, if you knew anything about health care you would know that the single most significant factor causing US health care to be more than 50% more expensive than other developed countries is price. And somehow you think that each individual citizen will be better equipped to demand and obtain lower prices for drugs than, say, the VA?
If that’s your position, Alan, than why are small businesses pushing so hard for Enzi’s AHP bill to allow them to capture the purchasing power of big companies?
My guess is Hubbard is another of the “every complex problem has a simple solution” guys.
What does this mean for you?
More wasted time as the Administration refuses to engage in meaningful efforts to address the health care crisis.
The workers comp PPO is dead. Well, dying. The era of large, national PPOs delivering a single generic discount-based model is coming to a close. Payers are finding that their medical costs are still going up; their managed care fees are climbing; and their customers are increasingly questioning their business models, fees, and outcomes.
Liberty Mutual, ESIS, the Hartford , Zenith and California’s State Insurance Fund are among the major workers compensation insurers and TPAs that are making significant changes to their provider networks, strategies, and partners. By the end of 2006, the comp PPO vendor landscape will have significantly shifted, with the dominant players (First Health, Focus, CorVel) losing share to regionals, specialty firms, and a couple of relatively new entrants including Aetna.
While that evolution will be good for the industry, it is neither far enough or fast enough for my liking. Here’s what the payers should be doing.
BTW, this subject is too big for a single post, so I’m breaking it down into a series…
The NCPDP meeting in Phoenix last week was more than just a few days sunning, golfing and dining. For those occupying the narrow-but-deep workers compensation niche, it was quite instructive. For example…
Kroger continues its anti-PBM stance; refusing to contract with any PBMs for workers compensation, instead choosing to send all their comp scripts to a third party biller. And as long as workers comp payers allow or enable their injured workers to get their scripts filled at Kroger stores, this problem will continue. Why? Because Kroger does not believe any comp payer can influence their comp script volume.
WorkingRx may be in trouble. The Albertson’s deal will likely result in WorkingRx losing its marquee customer (Albertson’s owns Sav-on and Osco’s, which are being sold to CVS), and therefore much of its clout with comp payers. This being the case, several PBMs and payers are scratching their heads over recent announcements that some comp PBMs are doing deals with WorkingRx…
Walgreen’s will not contract with any workers comp PBM or insurer for less than AWP-10%. That’s their public stance, and it appears to be consistent with their private contract negotiations as well.
Meanwhile, several payers have been in conversations with Third Party Solutions in a quest to find some way for payers, PBMs, and third party billers to work together. So far, TPS has been more “reasonable” than the other third party biller(s), but the inherent conflicts in business models and motivations are proving to be rather difficult to overcome.
A follow up from the ScripNet – WorkingRx court case – the transcript contains a potentially significant statement by WorkingRx’s attorney. When questioned by the judge abouit the surcharge placed on each script by WorkingRx, the lawyer admitted that WorkingRx’s right to reimbursement (and I’m paraphrasing here) was not any different from that of the retail pharmacies, and thus any surcharge was not reimburseable.
Finally, in a completely unrelated note, there is news out of California that legislative efforts to address the really significant issue of drug repackaging appear to be progressing.
And that’s today’s potpourri of drug talk.
Contrary to popular belief, most of the patients in emergency rooms have insurance, but are there because they can’t get in to see their regular physician or are waiting for an inpatient bed. A new study released today by the American College of Emergency Physicians (and reported in the LA Times) indicates that about 15% of patients in ERs were people without health insurance.
The statistics hold true across the board, even for high utilizers of ERs (those who visited 4 or more times per year).
The report refutes a common misconception that the uninsured make up a substantial percentage of ER admissions.
What does this mean for you?
The lesson I take from this is to always question your assumptions (to quote one of Ayn Rand’s heroes), and question your most basic assumptions about health care most aggressively.